Intestinal absorption of food antigens in coeliac disease

Similar documents
Gliadin antibody detection in gluten

Immunological studies in cows' milk protein-sensitive enteropathy

Diseases of the gastrointestinal system Dr H Awad Lecture 5: diseases of the small intestine

New immunofluorescent blood test for gluten

Diagnostic Testing Algorithms for Celiac Disease

Primary Care Update January 26 & 27, 2017 Celiac Disease: Concepts & Conundrums

November Laboratory Testing for Celiac Disease. Inflammation in Celiac Disease

screening test for coeliac disease

Disclosures GLUTEN RELATED DISORDERS CELIAC DISEASE UPDATE OR GLUTEN RELATED DISORDERS 6/9/2015

Challenges in Celiac Disease. Adam Stein, MD Director of Nutrition Support Northwestern University Feinberg School of Medicine

BIOPSY AVOIDANCE IN CHILDREN: THE EVIDENCE

Diagnosis Diagnostic principles Confirm diagnosis before treating

New Insights on Gluten Sensitivity

Combined cow's milk protein and gluten-induced

See Policy CPT CODE section below for any prior authorization requirements

Meredythe A. McNally, M.D. Gastroenterology Associates of Cleveland Beachwood, OH

GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE

Celiac & Gluten Sensitivity; serum

Activation of Innate and not Adaptive Immune system in Gluten Sensitivity

DEAMIDATED GLIADIN PEPTIDES IN COELIAC DISEASE DIAGNOSTICS

'Every time I eat dairy foods I become ill, could I have a milk allergy.? '. Factors involved in the development of cow's milk allergy:

Coeliac disease. Do I have coeliac. disease? Diagnosis, monitoring & susceptibilty. Laboratory flowsheet included

Diagnosis of Food Allergy by RAST

HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy

Immune mediated enteropathies. Aurora Tatu Bern 26/07/2017

Primary Prevention of Food Allergies

Pediatric Food Allergies: Physician and Parent. Robert Anderson MD Rachel Anderson Syracuse, NY March 3, 2018

The lab is open, the tests are available. Read on for much more information.

GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE AND PRESCRIPTION OF LOW LACTOSE INFANT FORMULA.

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

Peter HR Green MD. Columbia University New York, NY

Celiac Disease 1/13/2016. Objectives. Question 1. Understand the plethora of conditions or symptoms that require testing for Celiac Disease (CD)

CELIAC DISEASE - GENERAL AND LABORATORY ASPECTS Prof. Xavier Bossuyt, Ph.D. Laboratory Medicine, Immunology, University Hospital Leuven, Belgium

Living with Coeliac Disease Information & Support is key

Am I a Silly Yak? Laura Zakowski, MD. No financial disclosures

The Clinical Response to Gluten Challenge: A Review of the Literature

Cow`s Milk Protein Allergy. COW`s MILK PROTEIN ALLERGY Eyad Altamimi, MD

Gluten-Free China Gastro Q&A

A review of recent literature published in 2008 related to the timing of the introduction of solids Diana Langton IBCLC FCHN B.Health ScienceRM,RN

Celiac disease Crohn s disease Ulcerative colitis Pseudomembranous colitis

History of Food Allergies

Diet Isn t Working, We Need to Do Something Else

Spectrum of Gluten Disorders

Celiac Disease. Detlef Schuppan HARVARD MEDICAL SCHOOL

QUANTA Lite TM Gliadin IgG II For In Vitro Diagnostic Use CLIA Complexity: High

Malabsorption syndrome with cow's milk intolerance

Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease

CONTEMPORARY CONCEPT ON BASIC APSECTS OF GLUTEN-SENSITIVE ENTEROPATHY IN ELDERLY PATIENTS

Evidence Based Guideline

Celiac Disease. Gluten-Sensitive Enteropathy Celiac Sprue Non-tropical Sprue

Gluten sensitivity in Multiple Sclerosis Experimental myth or clinical truth?

Guideline for the Prescribing of Gluten Free Products (NUT5)

ImuPro shows you the way to the right food for you. And your path for better health.

Food Allergies: Fact from Fiction

TEST BULLETIN SUMMARY

Therapeutical implication of regulatory cells and cytokines in celiac disease

Sunderland Guidance on Prescribing Gluten Free Products

DR.RAJIV SHARMA BOOK SERIES 2

588-Complete Dietary Antigen Testing

OHTAC Recommendation

How to avoid complete elimination

The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Name of Policy: Human Leukocyte Antigen (HLA) Testing for Celiac Disease

EAT ACCORDING TO YOUR GENES. NGx-Gluten TM. Personalized Nutrition Report

Celiac Disease Ce. Celiac Disease. Barry Z. Hirsch, M.D. Baystate Pediatric Gastroenterology and Nutrition. baystatehealth.org/bch

ab Anti-Deamidated Gliadin Peptide (DGP) IgG ELISA Kit

No relevant financial relationships to disclose

prevalence 181 Atopy patch test, see Patch test

Celiac Disease. Sheryl Pfeil, MD The Ohio State University Division of Gastroenterology, Hepatology, and Nutrition. January 2015

The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Immuno Bloodprint Reactive Foods:

Clinical Immunology and Allergy Fellowship Program Kuwait Institute for Medical Specialization

Improving allergy outcomes. IgE and IgG 4 food serology in a Gastroenterology Practice. Jay Weiss, Ph.D and Gary Kitos, Ph.D., H.C.L.D.

Presentation and Evaluation of Celiac Disease

Alliance for Best Practice in Health Education

WHY IS THERE CONTROVERSY ABOUT FOOD ALLERGY AND ECZEMA. Food Allergies and Eczema: Facts and Fallacies

University of Tampere, Faculty of Medicine and Life Sciences Arvo building, Arvo Ylpön katu 34, Tampere, Finland

Dietary Management of Cow s Milk Protein Allergy

Larazotide Acetate. Alessio Fasano, M.D. Mucosal Biology Research Center and Center for Celiac Research University of Maryland School of Medicine

Sero Prevalence of Food allergy among Sudanese Patients in Khartoum state

The Use and Misuse of Fruit Juice in Pediatrics

COW S MILK PROTEIN ALLERGY IN CHILDREN

The nutritional benefits of an alternative firstclass meat-free protein source, Quorn.

Dietary management of food allergy & intolerance

Is It Celiac Disease or Gluten Sensitivity?

This Product May Contain Trace Amounts of Peanuts Educating Families & Patients About Food Allergies

Celiac Disease and Immunoglobulin A Deficiency: How Effective Are the Serological Methods of Diagnosis?

Gluten Free and Still Symptomatic

CELIAC DISEASE. Molly Jennings Deb McCafferty MS, RD

Celiac Disease: The Future. Alessio Fasano, M.D. Mucosal Biology Research Center University of Maryland School of Medicine

A young woman with fatigue

Objectives. Immunology 5/6/2012

Celiac Disease. Etiology. Food Intolerance:Celiac Disease and Gluten Sensitivity-A Guide for Healthy Lifestyles

Celiac Disease For Dummies By Sheila Crowe, Ian Blumer READ ONLINE

Coeliac disease catering gluten-free

Follow-up Management of Patients with Celiac Disease: Resource for Health Professionals

Food Allergies on the Rise in American Children

Food Intolerance & Expertise SARAH KEOGH CONSULTANT DIETITIAN EATWELL FOOD & NUTRITION

GI Allergy and Tolerance. Jon A. Vanderhoof, M.D. Division of Gastroenterology/Nutrition Boston Children s Hospital Harvard Medical School

INTEGRATIVE MEDICINE

Transcription:

Archives of Disease in Childhood, 1982, 57, 462-466 Intestinal absorption of food antigens in coeliac disease ROBERT W PITCHER-WILMOTT, IAN BOOTH, JOHN HARRIES, AND ROLAND J LEVINSKY Department ofimmunology and Child Health, Institute of Child Health, London SUMMARY Serum concentrations of ovalbumin,,-lactoglobulin, and antigen-antibody complexes were measured after jejunal administration of milk and raw egg in 6 children with active coeliac disease and in 4 controls. The results did not support the hypothesis of a generalised increase in absorption of antigens from the intestinal lumen in coeliac disease. It is well known that antigenically-intact food proteins are absorbed across the healthy gastrointestinal mucosa;1 the amounts absorbed are insignificant nutritionally but they are sufficient to immunise, and antibodies to cows' milk proteins may be found in most normal children.2 Increased absorption of food proteins has been demonstrated in infants recovering from diarrhoeas and it has been suggested that this is owing to mucosal damage. In coeliac disease, where profound mucosal damage occurs, it has been proposed that there may be a generalised increase in the absorption of antigens from the intestinal lumen and that an immunological response to these antigens contributes to the lesion of the small intestine.4 In common with several other gastrointestinal diseases, coeliac disease is associated with increased antibody responses to dietary proteins5-7 but there is no evidence that these antibodies are directly responsible for the intestinal disease. To test the hypothesis that absorption of dietary antigens is increased in active coeliac disease we have measured the serum concentrations of 3-lactoglobulin, ovalbumin, and antigen-antibody complexes (AAC) after administration of milk and egg to children with active coeliac disease, to children with coeliac disease in remission, and to control children. the sixth. Two patients were having pre-challenge biopsies while on gluten-free diets; they were free from symptoms and their biopsies were normal. Two further children in whom no organic cause was found were being investigated for suspected malabsorption and their biopsies were normal. The children therefore comprised a group of 6 patients with severe mucosal damage and 4 patients with normal mucosa. Methods The study was approved by the hospital's ethical committee and fully informed consent was obtained in each case. All patients were fasted overnight and, before the biopsy specimens were taken, the patients were given a mixture of milk (10 ml/kg; equivalent to 25 mg f-lactoglobulin/kg) and beaten egg (1.5 ml/kg; equivalent to 150 mg ovalbumin/kg) to a maximum volume of 500 ml via a jejunal-tube. Indwelling cannulae that had been inserted for drug administration during the biopsy procedure were used for blood sampling and small samples were taken just before administration of the milk/egg mixture and at 30 minutes and 1, 2,r3, 4, and's hours thereafter. Serum was separated within 2 hours, placed in aliquots, and stored at -70 C. Subjects Antigen detection assays. Concentrations of ovalbumin and 3-lactoglobulin were measured by a Ten children were studied while having a jejunal two-site solid-phase radioimmunoassay8 using polyvinyl plates. Results in ng/ml (limits of detection biopsy for investigation and confirmation of the diagnosis of coeliac disease. Six were having a postgluten challenge biopsy which showed severe partial expressed as ng/ml serum/g antigen administered/kg about 1 ng/ml) were read from standard curves and villous atrophy in 5, and subtotal villous atrophy in bodyweight. 462

Antigen-antibody complexes. Circulating AAC were measured by the polyethylene glycol (PEG) precipitation method. This was performed using 12% PEG in EDTA buffer ph 7.6 diluted with sample to give a final PEG concentration of 2 % and incubated overnight at 4 C.9 Precipitated immunoglobulins G, A, and M were measured by radial immunodiffusion10 and the results expressed as percentages of the total immunoglobulin concentrations of each class. Results Levels of ovalbumin and P-lactoglobulin were undetectable before administration of the test meal in each case. After the mixture of milk and egg had been given 4 coeliac patients showed progressive increases in serum ovalbumin concentrations (Fig. la) but the remaining 2 showed no evidence of absorption. Two of the 4 children with normal mucosa demonstrated absorption of ovalbumin (Fig. lb) which was similar in degree to that seen in the 4 patients with mucosal damage. The 2 children with normal biopsies who showed -Q 1-300 *200 00 100 Intestinal absorption offood antigens in coeliac disease 463 no detectable ovalbumin absorption were the coeliacs in remission. Although levels of ovalbumin did not correlate with having coeliac disease or with the degree of mucosal damage judged microscopically, the greatest degree of ovalbumin absorption occurred in a child with subtotal villous atrophy (the most severe form of mucosal damage). There was no good evidence of P-lactoglobulin absorption in 4 of the children with active coeliac disease (Fig. 2a) although the other 2 such children had pronounced increases in f3-lactoglobulin concentration after administration of the test meal. The maximum values in those 2 patients were greater than those of the 2 coeliacs in remission while the controls with normal mucosas did not develop measurable concentrations of P-lactoglobulin (Fig. 2b). There was no demonstrable absorption of P-lactoglobulin in the child with subtotal villous atrophy. None of the subjects had significant changes in IgG, IgA, or IgM complexes after antigen administration. The results for the children with normal mucosas are compared with those of the children with abnormal biopsies in the Table. One child with 0 "/2 1 2 3 4 5 0 "/2 1 2 3 4 Fig. 1 Serum concentrations of ovalbumin after food provocation in (a) 6 children with active coeliac disease and (b) 4 children with normal mucosa (open triangles are the normal children and closed triangles are coeliacs in remission). The broken line indicates the limit ofsensitivity for the assay. 400 (b)

464 Pitcher- Wilmott, Booth, Harries, and Levinsky 1600 r 1400 300 (b) (a) b 1200 1000 600 400 600 0~ ~~ ~ ~ ~ ~~~~~~~~0 0~~~~~~~~~~~~~~~~ 0 1/2 1 2 3 4 5 0 1/2 1 2 3 4 Fig. 2 Serum concentrations of /-lactoglobulin afterfoodprovocation in (a) 6 children with active coeliac disease and (b) 4 children with normal mucosa (open triangles are the normal children and closed triangles are coeliacs in remission). The broken line indicates the limit of sensitivity for the assay. Table Antigen-antibody complex levels (mean and range) afterfoodprovocation in 6 children with active coeliac disease compared with 4 controls Immunoglobulin Before Time afterfoodprovocation (hours) 200 30min 1 2 3 4 5 Patients IgG 1.88 1.43 1.54 1.94 1.65 1-45 1-60* 1.36-2-44 0.82-2.44 0-82-2-49 0.62-2-64 0.93-2-46 0.62-2-63 0-94-2.2 IgA 1.01 0.91 0.88 1.20 1-13 0.88 0-78* 0-1*64 0-1*78 0-1*60 0-1*82 0-1*61 0-1*30 0.34-1*38 IgM 3.89 4.61 4-26 3.71 4.41 4.04 4-21* 0-6-05 0-9-26 0-8-55 0-6-55 0-9-26 2*08-6-55 0-6-27 Controls IgG 1-70 1-18 1-65 1.05 1.17 1-30 - 0.87-3.03 0.65-2-03 0-70-2-83 0-52-1*96 0.90-1*56 0-85-2-28 - IgA 1.54 1-33 1.61 1.01 1.31 1-06 - 0-91-2-72 0.65-2-36 0.78-2-19 0.61-1-65 1-00-2-17 0-82-1-48 - IgM 5.25 3.98 4-08 3.85 3.74 4-59 - 32-7-7-81 2-20-5-19 3-134-94 3-27-4*73 2-37-5-71 3.07-6.29 - * Only 5 patients as one did not complete the study. Results are expressed as the percentage of total immunoglobulin for each class precipitated by 2% polyethylene glycol.

coeliac disease was found to have IgA deficiency; this was the child who also had severe partial villous atrophy on biopsy. Discussion These preliminary data do not support the concept of increased permeability of gut mucosa to food antigens in active coeliac disease. The evidence in support of this theory is circumstantial and rests on the demonstration of higher levels of food protein antibodies than normal in patients with coeliac disease5 6 7 and increased absorption of molecules such as lactulose."l However, other studies have shown reduced absorption of small molecules-such as polyethyleneglycol 400 and urea.12 13 The number of subjects in our study was small because of ethical constraints, but all were given equivalent amounts of antigen according to bodyweight and there were no apparent differences in absorption of 3-lactoglobulin and ovalbumin between children with damaged mucosa and those with normal mucosa. The levels were similar to those seen in our earlier study of dietary antigen absorption in term infants.14 Thus we are unable to confirm the notion that a damaged mucosa is more permeable to food antigens than a normal mucosa. In addition to mucosal permeability other factors-such as gut transit time, pancreatic function, local immunity, and the extent of the damaged mucosa-could theoretically influence circulating concentrations of food antigens. However, we did not feel justified in measuring these other variables in the children. It seems likely that the serum concentrations observed were in the main a function of intestinal permeability to the antigens. The detection of food protein antibodies in coeliac disease does not necessarily imply markedly increased absorption of food antigens because the amount of antigen required to immunise by the oral route is very small.'5 Such antibodies to food proteins could indeed be associated with decreased systemic absorption of these antigens if AAC form locally and deposition occurs within the gut wall. Further studies in animals have supported the concept that the mucosa with partial villous atrophy does not allow increased absorption of food antigens. We have studied rats infected with N-iippostrongylus brasiliensis (which causes partial villous atrophy) and at the time of maximal mucosal disease there was no increase in the absorption of food proteins.16 In the earlier studies it was shown that in healthy adults and children the physiological mechanism for clearing food antigens is by the formation of small IgA complexes.'7 In the present study there were no significant changes in the levels of IgG, IgA, and IgM Intestinal absorption offood antigens in coeliac disease 465 complexes measured by polyethylene glycol precipitation, a method which detects the larger complexes which may be of more pathological significance.18 A direct assay of the antigen content of the AAC was not performed but increases seem unlikely in view of the low levels of AAC. This suggests that the AAC demonstrated in other studies of coeliac disease in remission and relapse19 20 may have been non-specific and that they did not necessarily contain food protein antigens. We are grateful for the advice and help given by Dr Roberto Paganelli who initially developed the food antigen assays. References Wilson S J, Walzer M. Absorption of undigested proteins in human beings. IV. Absorption of unaltered egg protein in infants and in children. Am J Dis Child 1935; 50: 49-54. 2 Peterson R D A, Good R A. Antibodies to cows' milk proteins-their presence and significance. Pediatrics 1963; 31: 209-21. 3 Gruskay F L, Cooke R E. The gastrointestinal absorption of unaltered protein in normal infants and in infants recovering from diarrhea. Pediatrics 1955; 16: 763-9. 4 Allan Walker W. Antigen absorption from the small intestine and gastrointestinal disease. Pediatr Clin North Am 1975; 22: 731-46. 5 Taylor K B, Truelove S C, Thomson D L, Wright R. An immunological study of coeliac disease and idiopathic steatorrhoea. Serological reactions to gluten and milk proteins. Br MedJ 1961; ii: 1727-31. 6 Kivel R M, Kearns D H, Liebowitz D. Significance of antibodies to dietary proteins in the serums of patients with nontropical sprue. N Engl J Med 1964; 271: 769-72. 7 Kenrick K G, Walker-Smith J A. Immunoglobulins and dietary protein antibodies in childhood coeliac disease. Gut 1970; 11: 635-40. 8 Paganelli R, Levinsky R J. Solid phase radioimmunoassay for detection of circulating food protein antigens in human serum. J Immunol Methods 1980; 37: 333-41. 9 Dambuyant C, Burton-Kee J, Mowbray J F. Demonstration of two disease specific antigens in circulating immune complexes. Clin Exp Immunol 1979; 37: 424-31. 10 Mancini G, Carbonara A 0, Heremans J F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-54. Menzies I S, Pounder R, Heyer S, et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; ii: 1107-9. 12 Chadwick V S, Phillips S F, Hofmann A F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977; 73: 247-51. 13 Fordtran J S, Rector F C, Locklear T W, Ewton M F. Water and solute movement in the small intestine of patients with sprue. J Clin Invest 1967; 46: 287-98. 14 Roberton D M, Paganelli R, Dinwiddie R, Levinsky R J. Milk antigen absorption in the preterm and term neonate. Arch Dis Child 1982; 57: 369-72.

466 Pitcher- Wilmott, Booth, Harries, and Levinsky 15 Jarrett E E E, Haig D M, McDougall W, McNulty E. Rat IgE production. II. Primary and booster reaginic antibody responses following intradermal or oral immunization. Immunology 1976; 30: 671-7. 16 Reinhardt M C, Paganelli R, Levinsky R J, Pincott J, Harries J T. Intestinal uptake of antigens in rats maintained on normal and protein deficient diets and infected with Nippostrongylus brasiliensis (abstract). Immunobiology 1981; 160: 92. 17 Brostoff J, Carini C, Wraith D G, Paganelli R, Levinsky R J. Immune complexes in atopy. In: Pepys J, Edwards A M, eds. The mast cell. London: Pitman, 1979: 380-93. 18 World Health Organisation Scientific Group. The role of immune complexes in disease. Technical Report Series No 606. Geneva: WHO, 1977: 5-58. British Paediatric Association '9 Mohammed I, Holborow E J, Fry L, Thompson B R, Hoffbrand A V, Stewart J S. Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet 1976; ii: 487-90. 20 Doe W F, Booth C C, Brown D L. Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis. Lancet 1973; 1: 402-3. Correspondence to Dr R J Levinsky, Institute of Child Health, 30 Guilford Street, London WClN 1EH. Received 8 December 1981 Annual meetings 1983 12-16 April York University 1984 10-14 April York University 1985 16-20 April York University 1986 15-19 April York University Arch Dis Child: first published as 10.1136/adc.57.6.462 on 1 June 1982. Downloaded from http://adc.bmj.com/ on 25 September 2018 by guest. Protected by